Correlation Between CytomX Therapeutics and Protara Therapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Protara Therapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Protara Therapeutics.
Diversification Opportunities for CytomX Therapeutics and Protara Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between CytomX and Protara is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Protara Therapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Protara Therapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Protara Therapeutics. In addition to that, CytomX Therapeutics is 1.03 times more volatile than Protara Therapeutics. It trades about -0.2 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest 558.00 in Protara Therapeutics on November 2, 2024 and sell it today you would lose (65.00) from holding Protara Therapeutics or give up 11.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Protara Therapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Protara Therapeutics |
CytomX Therapeutics and Protara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Protara Therapeutics
The main advantage of trading using opposite CytomX Therapeutics and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology | Protara Therapeutics vs. Xilio Development |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |